Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:57 PM
Ignite Modification Date:
2025-12-24 @ 9:57 PM
NCT ID:
NCT00774332
Eligibility Criteria:
Inclusion Criteria:
* Patients with relapsed/resistant acute lymphoblastic leukemia
* Patients must be between 15 and 65 years of age.
* Estimated life expectancy of more than 3 months
* ECOG performance status of 2 or lower, Karnofsky scale \> 60 (see appendix I)
* Adequate cardiac function (EF\>45%) on echocardiogram or MUGA scan
* Adequate kidney function (estimated Ccr \>50 ml/min)
Exclusion Criteria:
* Patients with CNS involvement of leukemic blasts will not be excluded.
* Patients with extramedullary relapse(s) only will be excluded.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
15 Years
Maximum Age:
65 Years
Study:
NCT00774332
Study Brief:
Protocol Section:
NCT00774332